Skip to content

Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07797088
Enrollment
14
Registered
2026-09-01
Start date
2026-09-25
Completion date
2026-12-31
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Healthy Adult, High Altitude, High Altitude Effects, Six-minute Walk Test

Keywords

hypoxia, high altitude, six-minute walking distance, Health, NYHA, Exercise testing

Brief summary

To study the effect of a re-ascent after a one-week stay at sea level (after prior descent from 2850m) to high altitude (Quito Ecuador: 2850m) on six-minute walking distance and other scores in healthy individuals, who live permanently \>2600m.

Detailed description

The aim of this research is to investigate the six-minute walking distance and other scores before and after re-ascent (sea level for 7 days vs. re-ascent to 2850m) in healthy individuals, who permanently live at high altitude over 2600m.

Interventions

After 7 days at sea level return/re-ascent to their usual living altitude at 2850m

Sponsors

Silvia Ulrich Somaini
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Healthy individuals living permanently \> 2600m around Quito (Ecuador) will be assessed after 7 days at sea level and after re-ascent to 2850m

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-80 years and of all genders * Permanent residence \> 2600 m * healthy: no self-perceived cardiopulmonary disease limiting daily activities * written informed consent to participate in the study.

Exclusion criteria

* Age \<18 years or \>80 years * Participants who cannot follow the study investigations * Participants permanently living \< 2600m * Participants who traveled and stayed overnight at altitudes \<2000 m in the past 4 weeks. * any self-perceived cardiopulmonary disease limiting daily activities

Design outcomes

Primary

MeasureTime frameDescription
Six-minute walking distance after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in six-minute walking distance 6MWD between sea level (after one-week stay) and day after re-ascent at 2850m in healthy individuals

Secondary

MeasureTime frameDescription
SpO2 at rest and end-exercise after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Heart rate at rest and end-exercise after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in heart rate at rest and end-exercise between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Blood pressure at rest and end-exercise after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in blood pressure at rest and end-exercise between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Dyspnea and leg discomfort sensation after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in dyspnea and leg discomfort sensation (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
NYHA functional class after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
Quality of life after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in quality of life score (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
General well-being after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
Six-minute walking test pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in six-minute walking distance (6MWD) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
SpO2 at rest and end-exercise pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Heart rate at rest and end-exercise pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in heart rate at rest and end-exercise with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Blood pressure at rest and end-exercise pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in blood pressure at rest and end-exercise with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Dyspnea and leg discomfort pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in dyspnea and leg discomfort (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
NYHA functional class pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Quality of life pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in quality of life (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
General well-being pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals

Countries

Switzerland

Contacts

CONTACTSilvia Ulrich, Prof. Dr. med.
silvia.ulrich@usz.ch+41442552220
CONTACTMichael Furian, Prof. Dr. sc. ETH
+41442552220
PRINCIPAL_INVESTIGATORSilvia Ulrich

University Hospital Zurich, Departement of Pulmonology

PRINCIPAL_INVESTIGATORRodrigo Hoyos

Hospital Carlos Andrade Marin of Quito, Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026